FDA
approval
· 2021-12-20
FDA Approved: VOCABRIA — Supplemental Application (ViiV Healthcare Company)
Summary
The FDA has approved a supplemental application for VOCABRIA (cabotegravir sodium) from ViiV Healthcare Company. This action supplements the existing labeling/i…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VOCABRIA (CABOTEGRAVIR SODIUM)